Crit Care Clin. 2018 Jan;34(1):97-106. doi: 10.1016/j.ccc.2017.08.007. Epub 2017 Oct 6.
PMID:29149944
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response.
Dragomir MP, Fuentes-Mattei E, Winkle M, Okubo K, Bayraktar R, Knutsen E, Qdaisat A, Chen M, Li Y, Shimizu M, Pang L, Liu K, Liu X, Anfossi S, Zhang H, Koch I, Tran AM, Mohapatra S, Ton A, Kaplan M, Anderson MW, Rothfuss SJ, Silasi R, Keshari RS, Ferracin M, Ivan C, Rodriguez-Aguayo C, Lopez-Berestein G, Georgescu C, Banerjee PP, Basar R, Li Z, Horst D, Vasilescu C, Bertilaccio MTS, Rezvani K, Lupu F, Yeung SC, Calin GA.
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate.
Vaccine. 2023 Oct 6;41(42):6327-6338. doi: 10.1016/j.vaccine.2023.08.081. Epub 2023 Sep 14.
PMID:37689543
Effects of carrimycin on biomarkers of inflammation and immune function in tumor patients with sepsis: A multicenter double-blind randomized controlled trial.
Nan C, Zhang X, Huang W, Zhu B, Zhao J, Lu S, Xian L, Liu K, Ma G, Yang W, Huang M, Zhou D, Zhang M, Duan Y, Wu G, Jiang Z, Zhang L, He X, Chen Y, Xing X, Wang C, Wang D, Yu K; Cancer Critical Care Medicine Committee of the Chinese Anti-Cancer Association.
Pharmacol Res. 2023 Dec;198:106991. doi: 10.1016/j.phrs.2023.106991. Epub 2023 Nov 19.